Patient Group Directions

Applied filters

Patient Group Directions

Care Setting (14)
- Emergency medicine and urgent care (5)
- Occupational Health (6)
- Palliative and End of Life Care (1)
- Primary Care (2)
Events (1)
- Past Events (1)
Guidance (150)
- Administering (10)
- Dosing (2)
- Medication Safety (1)
- Patient Group Directions (150)
- Policy, Commissioning and Managerial (8)
- Safety in Pregnancy (5)
- Service advice and planning (3)
- Supply (11)
- Unlicensed medicines (2)
Medicine (87)
- Aciclovir (2)
- Amoxicillin (1)
- Aspirin (1)
- Azithromycin (1)
- Benzylpenicillin (2)
- Ceftriaxone (1)
- Clarithromycin (5)
- Clotrimazole (2)
- Co-amoxiclav (1)
- Copper (1)
- Cytisinicline (1)
- Diamorphine (1)
- Diazepam (2)
- Doxycycline (4)
- Emtricitabine + Tenofovir alafenamide (1)
- Emtricitabine + Tenofovir disoproxil (1)
- Erythromycin (5)
- Estradiol + Dienogest (1)
- Estradiol + Nomegestrol (1)
- Ethinylestradiol + Desogestrel (1)
- Ethinylestradiol + Drospirenone (1)
- Ethinylestradiol + Etonogestrel (1)
- Ethinylestradiol + Gestodene (1)
- Ethinylestradiol + Levonorgestrel (1)
- Ethinylestradiol + Norelgestromin (1)
- Ethinylestradiol + Norethisterone (1)
- Ethinylestradiol + Norgestimate (1)
- Etonogestrel (2)
- Flucloxacillin (2)
- Fluconazole (1)
- Flumazenil (1)
- Fluticasone (1)
- Folic acid (1)
- Fusidic acid (1)
- Gadobutrol (1)
- Gadopiclenol (1)
- Gadoteric acid (1)
- Gadoteridol (1)
- Gadoxetic acid (1)
- Hydrogen peroxide (1)
- Hyoscine butylbromide (1)
- Imiquimod (1)
- Influenza vaccine (3)
- Iodixanol (1)
- Iohexol (1)
- Iomeprol (1)
- Iopamidol (1)
- Ioversol (1)
- Ketamine (1)
- Levonorgestrel (2)
- Lidocaine (5)
- Lidocaine + Prilocaine (1)
- Malathion (1)
- Medroxyprogesterone (2)
- Meglumine gadobenate (1)
- Metronidazole (2)
- Midazolam (2)
- Mifepristone (1)
- Misoprostol (1)
- Mometasone (1)
- Morphine (1)
- Nitrofurantoin (1)
- Permethrin (1)
- Phenoxymethylpenicillin (2)
- Podophyllotoxin (1)
- Prilocaine (1)
- Progesterone (1)
- Raltegravir (1)
- Sodium chloride (1)
- Tenofovir disoproxil + Emtricitabine (1)
- Terbutaline (1)
- Tramadol (1)
- Tranexamic acid (1)
- Trimethoprim (1)
- Ulipristal (1)
- Valaciclovir (1)
- Varenicline (1)
Publications (93)
- Explainer videos (4)
- Research and audits (3)
- Templates (86)
Specialty (78)
- Infection and infectious diseases (30)
- Neurological disorders (1)
- Obstetrics and gynaecology (1)
- Public Health (1)
- Radiology (13)
- Renal and urologic disorders (2)
- Reproductive health (14)
- Respiratory disorders (13)
- Sexual health (14)
- Skin disorders (14)
- Smoking cessation (2)
- Vaccinating (3)
Training and Development (6)

Sodium chloride 0.9% in multi injector devices

20 July 2023SPS PGD template for administering sodium chloride 0.9% intravenously for imaging investigations and procedures by registered Radiographers.

Intravenous hyoscine butylbromide

24 April 2025SPS PGD template for administering intravenous hyoscine butylbromide for imaging investigations by registered Radiographers.

Considerations for developing national PGD and protocol templates

3 January 2024Decisions to develop PGD templates under the national Medicines Governance Do Once Programme depend on a variety of factors and advice on exclusions is given.

Patient Specific Directions (PSD)

10 June 2020This article describes Patient Specific Directions and the requirements for their writing and use

PGD supply and administration explainer videos

1 May 2024Short explanatory videos about the supply and administration of medicines under Patient Group Directions (PGDs).

Omeprazole for use within antenatal and maternity services

20 April 2023SPS protocol templates for the supply and administration of omeprazole for caesarean section by registered midwives.

Buccal midazolam for seizures or symptomatic cocaine toxicity management

5 October 2021SPS PGD template for administering buccal midazolam for the management of seizures by registered Paramedics and Nurses.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

10 November 2025Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Extension of expiry date of a Patient Group Direction

10 November 2025This article advises on the extension to the expiry date of a PGD where a full review and re-authorisation has not taken place.

Malathion for scabies

27 November 2025SPS PGD template for supply of malathion for the treatment of scabies in specified patient groups.